Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen F Kerr

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
Reply to A.J. Vickers et alKathleen F Kerr, Marshall Brown, Holly Janes
Clinical Trials (London, England)|August 19, 2017
Comparisons of cancer staging systems should be based on overall performance in the populationKathleen F Kerr, Michael LeBlanc, Holly Janes
Statistics in Medicine|August 15, 2020
Developing biomarker combinations in multicenter studies via direct maximization and penalizationAllison Meisner, Chirag R Parikh, Kathleen F Kerr
Statistical Methods in Medical Research|November 22, 2017
Biomarker combinations for diagnosis and prognosis in multicenter studies: Principles and methodsAllison Meisner, Chirag R Parikh, Kathleen F Kerr
Diagnostic and Prognostic Research|May 17, 2019
Using ordinal outcomes to construct and select biomarker combinations for single-level predictionAllison Meisner, Chirag R Parikh, Kathleen F Kerr
American Journal of Epidemiology|August 10, 2012
Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical contextKathleen F Kerr, Aasthaa Bansal, Margaret S Pepe
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 21, 2019
The Importance of Uncertainty and Opt-In v. Opt-Out: Best Practices for Decision Curve AnalysisKathleen F Kerr, Tracey L Marsh, Holly Janes
Journal of Hepatology|May 31, 2019
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratificationGeorge N Ioannou, Pamela Green, Kathleen F Kerr, et al.
Statistics in Medicine|January 9, 2013
Testing for improvement in prediction model performanceMargaret Sullivan Pepe, Kathleen F Kerr, Gary Longton, et al.
Biometrical Journal. Biometrische Zeitschrift|April 19, 2021
Combining biomarkers by maximizing the true positive rate for a fixed false positive rateAllison Meisner, Marco Carone, Margaret S Pepe, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
Reply to A.J. Vickers et alKathleen F Kerr, Marshall Brown, Holly Janes
Clinical Trials (London, England)|August 19, 2017
Comparisons of cancer staging systems should be based on overall performance in the populationKathleen F Kerr, Michael LeBlanc, Holly Janes
Statistics in Medicine|August 15, 2020
Developing biomarker combinations in multicenter studies via direct maximization and penalizationAllison Meisner, Chirag R Parikh, Kathleen F Kerr
Statistical Methods in Medical Research|November 22, 2017
Biomarker combinations for diagnosis and prognosis in multicenter studies: Principles and methodsAllison Meisner, Chirag R Parikh, Kathleen F Kerr
Diagnostic and Prognostic Research|May 17, 2019
Using ordinal outcomes to construct and select biomarker combinations for single-level predictionAllison Meisner, Chirag R Parikh, Kathleen F Kerr
American Journal of Epidemiology|August 10, 2012
Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical contextKathleen F Kerr, Aasthaa Bansal, Margaret S Pepe
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 21, 2019
The Importance of Uncertainty and Opt-In v. Opt-Out: Best Practices for Decision Curve AnalysisKathleen F Kerr, Tracey L Marsh, Holly Janes
Journal of Hepatology|May 31, 2019
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratificationGeorge N Ioannou, Pamela Green, Kathleen F Kerr, et al.
Statistics in Medicine|January 9, 2013
Testing for improvement in prediction model performanceMargaret Sullivan Pepe, Kathleen F Kerr, Gary Longton, et al.
Biometrical Journal. Biometrische Zeitschrift|April 19, 2021
Combining biomarkers by maximizing the true positive rate for a fixed false positive rateAllison Meisner, Marco Carone, Margaret S Pepe, et al.
Pageof 14